Hosted on MSN1mon
Virpax Pharmaceuticals sets public offering at $0.20 per shareFurthermore, Virpax Pharmaceuticals has made amendments to the contracts of CEO Jatinder Dhaliwal and CFO Usama Chaudhry, ensuring alignment with legal regulations. The company also underwent ...
Hosted on MSN1mon
Virpax Pharmaceuticals Advances Pain Management with Promising Probudur Study Results“These positive results are consistent with what we at Virpax have previously observed and we are encouraged by these findings,” said Jatinder Dhaliwal, Chief Executive Officer of Virpa ...
Hosted on MSN1mon
Virpax Pharmaceuticals stock hits 52-week low at $0.29The company has also made amendments to the independent contractor agreements of its CEO and CFO, Jatinder Dhaliwal and Usama Chaudhry, respectively. The contractual terms for both executives have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results